Dx & Vx Co., Ltd.
A bio-healthcare company specializing in diagnostics and mRNA vaccine development.
180400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7180400004
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 디지털로 173, 금천구
- Website:
- https://www.dxvx.com/
- Sector:
- Manufacturing
Description
Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-02-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-02-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-02-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | ||
| 2025-02-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-02-13 00:00 |
주권매매거래정지 (관리종목지정우려)
|
Korean | 5.0 KB | ||
| 2025-02-13 00:00 |
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
|
Korean | 22.8 KB | ||
| 2025-01-09 00:00 |
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 44.2 KB | ||
| 2025-01-09 00:00 |
철회신고서
|
Korean | 5.5 KB | ||
| 2024-12-30 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.9 KB | ||
| 2024-12-20 00:00 |
임시주주총회결과
|
Korean | 7.5 KB | ||
| 2024-12-16 00:00 |
투자판단관련주요경영사항 (범용 COVID19 백신 개발을 위한 기술도입계약 체결)
|
Korean | 10.7 KB | ||
| 2024-12-12 00:00 |
투자판단관련주요경영사항 (항암백신(OVM200) 개발을 위한 기술도입계약 체결)
|
Korean | 10.6 KB | ||
| 2024-12-09 00:00 |
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 40.1 KB | ||
| 2024-12-04 00:00 |
주주총회소집공고
|
Korean | 77.3 KB |
Automate Your Workflow. Get a real-time feed of all Dx & Vx Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dx & Vx Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dx & Vx Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
